🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Zota Health Care Limited ZOTA NSEPHARMA

Healthcare · Biotechnology · India
https://www.zotahealthcare.com
Company Profile ↓
₹1,398.50
+8.33% 1Y
Mkt Cap₹4,004.61 Cr
P/E-67.63
P/B13.95
Div. Yield0.07%
52W High₹1,687.00
52W Low₹1,043.10
Book Value₹242.18
EPS (TTM)₹-20.68

Company Overview

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 56.7% CAGR over the past five years.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.39.

Recent Developments

  • Mar 2026 Revenue of ₹538.66 Cr (+83.9% YoY); net profit ₹-73.94 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +83.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR 56.7%, profit CAGR -393.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:56.71%
1 Year:83.86%

Compounded Profit Growth

5 Years:-393.59%
1 Year:-

Stock Price Performance

1 Year:+8.33%
6 Months:-4.41%
3 Months:+5.03%
1 Month:+12.18%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 55% of range
₹1,043.10 ₹1,687.00
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)58.34 · Neutral
Price Performance
1M+12.18%
3M+5.03%
6M-4.41%
1Y+8.33%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 56.7% over 5 years.

CONS

  • Earnings shrank at -393.6% CAGR over 5 years.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-67.63
Industry PE
39.97
Forward P/E
-
PEG Ratio
-
Book Value
₹242.18
Price to Book
13.95
P/S
8.09
EV/EBITDA
278.05
Dividend Yield
0.07%

Growth (CAGR)

Revenue 5Y
56.71%
Profit 5Y
-393.59%
Revenue (YoY)
83.86%
Earnings (YoY)
-

Profitability & Returns

ROCE
-6.99%
ROE
-10.66%
ROA
-6.54%
Profit Margin
-13.73%
Op Margin
-11.87%
Gross Margin
60.28%
EPS (Latest Qtr)
₹-4.13
EPS (TTM)
₹-20.68

Balance Sheet & Liquidity

Debt/Equity
0.39
Quick Ratio
1.11
Current Ratio
1.93
Debt
₹270.44 Cr
Total Assets
₹1,131.05 Cr
Current Assets
₹457.17 Cr
Working Capital
₹219.89 Cr

Ownership

Promoter Holding
0.00%
Chg in Prom Hold
-
FII / Inst Holding
1.44%
Chg in FII Hold
-13.17%

Financial Snapshot

Enterprise Value
₹4,004.61 Cr
Total Revenue (TTM)
₹538.66 Cr
EBITDA
₹19.98 Cr
Free Cash Flow
₹-197.36 Cr
Operating Cash Flow
₹-84.43 Cr
Shares Outstanding
₹2.86 Cr
Gross Margin
60.28%
Payout Ratio
53.20%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ZOTA Zota Health Care Limited NSEPHARMA 1,398.50 -67.63 ₹4,004.61 Cr 0.07% -6.99% -10.66% 56.71% -393.59%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 37.00 Cr39.00 Cr45.00 Cr47.00 Cr50.00 Cr56.00 Cr67.00 Cr72.12 Cr97.27 Cr103.58 Cr129.00 Cr142.95 Cr163.18 Cr
Cost of Revenue -------31.83 Cr47.87 Cr45.13 Cr-56.77 Cr59.62 Cr
Gross Profit -------40.29 Cr49.40 Cr58.45 Cr-86.18 Cr103.56 Cr
Operating Expenses 36.00 Cr37.00 Cr41.00 Cr44.00 Cr51.00 Cr58.00 Cr68.00 Cr57.71 Cr61.25 Cr69.17 Cr123.00 Cr108.87 Cr121.87 Cr
Operating Income -3.00 Cr-2.00 Cr-1.00 Cr-2.00 Cr-8.00 Cr-9.00 Cr-11.00 Cr-17.42 Cr-11.85 Cr-10.72 Cr-13.00 Cr-22.70 Cr-18.31 Cr
EBITDA 1.00 Cr1.00 Cr4.00 Cr3.00 Cr-1.00 Cr-1.00 Cr-1.00 Cr-5.56 Cr3.47 Cr4.83 Cr6.00 Cr1.28 Cr5.91 Cr
Interest Expense 1.00 Cr1.00 Cr1.00 Cr1.00 Cr2.00 Cr3.00 Cr3.00 Cr1.57 Cr3.46 Cr3.24 Cr4.00 Cr4.97 Cr5.32 Cr
Pretax Income -3.00 Cr-3.00 Cr-1.00 Cr-3.00 Cr-10.00 Cr-12.00 Cr-13.00 Cr-18.48 Cr-14.30 Cr-13.08 Cr-14.00 Cr-25.95 Cr-26.42 Cr
Tax Provision 45.00 L-3.00 L-49.00 L-21.00 L2.70 Cr-60.00 L52.00 L46.14 L-1.42 Cr69.31 L-1.82 Cr3.69 Cr-11.96 Cr
Net Income -3.00 Cr-3.00 Cr-2.00 Cr-3.00 Cr-7.00 Cr-13.00 Cr-12.00 Cr-18.68 Cr-12.89 Cr-14.32 Cr-16.00 Cr-29.50 Cr-14.17 Cr
Diluted EPS -1.05-1.13-0.64-1.14-2.68-4.79-4.41-6.80-4.57-4.92-5.20-9.44-4.13

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2011Mar 2012Mar 2014Mar 2015Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 25.00 Cr38.00 Cr50.00 Cr56.00 Cr85.00 Cr95.00 Cr106.00 Cr-139.96 Cr180.49 Cr292.97 Cr538.66 Cr
Cost of Revenue --------84.83 Cr100.15 Cr137.30 Cr213.97 Cr
Gross Profit --------55.13 Cr80.34 Cr155.67 Cr324.69 Cr
Operating Expenses 21.00 Cr33.00 Cr43.00 Cr47.00 Cr77.00 Cr90.00 Cr105.00 Cr-58.95 Cr92.95 Cr204.60 Cr388.60 Cr
Operating Income 4.00 Cr4.00 Cr5.00 Cr6.00 Cr7.00 Cr3.00 Cr-2.00 Cr--3.83 Cr-12.61 Cr-48.93 Cr-63.91 Cr
EBITDA 4.00 Cr5.00 Cr6.00 Cr8.00 Cr8.00 Cr5.00 Cr1.00 Cr-9.75 Cr8.21 Cr-3.66 Cr19.98 Cr
Interest Expense 01.00 Cr1.00 Cr1.00 Cr000-2.49 Cr4.20 Cr10.78 Cr17.36 Cr
Pretax Income 3.00 Cr3.00 Cr5.00 Cr6.00 Cr8.00 Cr4.00 Cr-0--4.69 Cr-16.16 Cr-57.64 Cr-79.84 Cr
Tax Provision 1.02 Cr99.00 L1.65 Cr1.98 Cr2.32 Cr1.16 Cr0-1.08 Cr-1.82 Cr-90.55 L-5.76 Cr
Net Income 2.00 Cr2.00 Cr3.00 Cr4.00 Cr6.00 Cr3.00 Cr-0--5.77 Cr-14.35 Cr-56.40 Cr-73.94 Cr
Diluted EPS 2.171.431.852.122.261.12-0.093.58-2.29-5.59-20.68-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2011Mar 2012Mar 2014Mar 2015Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 20.00 Cr29.00 Cr35.00 Cr40.00 Cr90.00 Cr88.00 Cr85.00 Cr-158.11 Cr228.33 Cr439.14 Cr1,131.05 Cr
Current Assets --------84.17 Cr111.62 Cr184.16 Cr457.17 Cr
Cash & Equivalents --------9.19 L67.67 L2.13 Cr7.77 Cr
Inventory --------41.79 Cr53.77 Cr105.68 Cr192.64 Cr
Receivables --------27.83 Cr27.24 Cr40.50 Cr73.52 Cr
Total Liabilities --------77.76 Cr138.35 Cr211.99 Cr434.89 Cr
Current Liabilities --------40.52 Cr73.68 Cr100.61 Cr237.27 Cr
Long Term Debt --------004.99 Cr6.37 Cr
Total Debt 3.00 Cr6.00 Cr5.00 Cr5.00 Cr000-45.12 Cr95.28 Cr139.60 Cr270.44 Cr
Total Equity 12.00 Cr13.00 Cr16.00 Cr18.00 Cr69.00 Cr69.00 Cr67.00 Cr-80.36 Cr89.98 Cr223.68 Cr693.49 Cr
Shares Outstanding -------2.52 Cr2.52 Cr2.58 Cr2.86 Cr-

Cash Flows (Annual)

Figures in INR.

Metric Mar 2011Mar 2012Mar 2014Mar 2015Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow --3.00 Cr5.00 Cr-3.00 Cr6.00 Cr-1.00 Cr--2.01 Cr-5.98 Cr-49.96 Cr-84.43 Cr
Investing Cash Flow ---1.00 Cr-1.00 Cr9.00 Cr-4.00 Cr4.00 Cr-14.70 Cr-12.90 Cr-92.19 Cr-313.56 Cr
Financing Cash Flow ---2.00 Cr-4.00 Cr-6.00 Cr-3.00 Cr-2.00 Cr--13.88 Cr18.78 Cr144.76 Cr489.94 Cr
Capital Expenditure ---1.00 Cr-1.00 Cr-3.00 Cr-7.00 Cr-1.00 Cr--12.50 Cr-16.71 Cr-45.98 Cr-112.93 Cr
Free Cash Flow --2.00 Cr4.00 Cr-6.00 Cr-1.00 Cr-2.00 Cr--14.51 Cr-22.69 Cr-95.94 Cr-197.36 Cr
Net Change in Cash --00-1.00 Cr-1.00 Cr1.00 Cr--1.18 Cr-11.07 L2.61 Cr91.95 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2011Mar 2012Mar 2014Mar 2015Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------39.4%44.5%53.1%60.3%
Operating Margin % 16.0%10.5%10.0%10.7%8.2%3.2%-1.9%--2.7%-7.0%-16.7%-11.9%
Net Margin % 8.0%5.3%6.0%7.1%7.1%3.2%-0.0%--4.1%-7.9%-19.3%-13.7%
ROE % 16.7%15.4%18.8%22.2%8.7%4.3%-0.0%--7.2%-15.9%-25.2%-10.7%
ROCE % ---------3.3%-8.2%-14.5%-7.2%

Shareholding Pattern

Insiders
0.00%
Institutions
1.44%
Public Float
1.44%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ZOTA

Google News Mon, 20 Oct 2025

ZOTA Stock Price and Chart — NSE:ZOTA - TradingView

<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE04bFFXRzZPb3VEcEdndGs0bGdMYnZycllRT1VLNXpNcXI1MzJaVG14MUdHR3JMRC1ZUHNvcXhQS3hCLUpnclEyUGpWUmVYOWIwalhSTWZwNS0?oc=5" target="_blank">ZOTA Stock Price and Chart — NSE:ZOTA</a>&nbsp;&…

Google News ue, 10 Feb 2026

Why We're Not Concerned About Zota Health Care Limited's (NSE:ZOTA) Share Price - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxPRmpuYXIxNUpJTzlXN211cWxWdDdMTmZ1VVliN2RpYXBJcVNGUEdFZ3lYdXN1eVQ0NlBWbjlhcUJVRFRJelB0bWJ5THFTT2paNFBBQ1ZxUC1PLVBSMXFUNjgzY2tjaXViOWw5U05YYkN2cW1PcEFQWmNpSkFJMFJUY1dIYUtvMUVDcjR4NH…

Google News Fri, 19 Jun 2026

Zota Health Care Shares May Rally 41% says Nirmal Bang — Check New Target Price - NDTV Profit

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQMEEwZGZ2MGJrRHpkMDJOSlM2SlZLTXJEUExkSWNzdU1ZVlBVX281SlY3emIxc2RzdUtaOUdORGNtdkRZM195dHU4VloxRXBFVFp5N2dGdl9kWEpCRktNSnp6aWlJSE95NHRRV1RPdlpnSjk0ZHR4SU9GZy1DVDRRd3Joa1ViQTFYcElraU…

Google News Mon, 22 Jun 2026

Zota Health Care acquires shares in KMHP Ventures for ₹2 Cr - scanx.trade

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOejZWaEJiSnBZaVdxNjZlak9tYVhSWjkzZzdrMkIzSkItdE43VTd4a1dEX09TXy1vR2g2QVFnZEJIeFp5TjlCZERXcGRqMExxQkRZZHVBeW44Zzd1YkVNbzZhYVR1VmFlNlpOTWpSMTByMnhLdmxFV05LMTVmN0NWZGw0ZEdYUUJZY2VkSl…

Google News Sat, 06 Jun 2026

With Zota Health Care Up 12%, Insider Buyers Count Their Returns - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxQXzZnSGpqMmZXbW5MQVo5R1Jid3pfbzcyazFZX2Y1V29kNDRFdmZRV3M3TWR6Y1IyTGwxNjZmVUJMSS03OC0zRk5xbUhETU0zTnNnTVJBbEpwTk5COHExb1pmdV96QUhqb09jdzNFNk53ZzBBd2dXOHdGaUh1LVA0Ylp2ZXRZRXAtVkdQVk…

Google News Fri, 08 May 2026

Entrada’s stock drops as DMD drug’s efficacy falls short - Clinical Trials Arena

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQQ3lEX0Y1TmFEd1liRnItRXp2N2U3dF9hWjRhNVpZOHh6V1ZYREpJQkZzLVpmR1BjckY3OGVrRGVYM3pjbVZ3T3AyYTNqRGg0dk13MGhfTlJyLXN2ZGF5TmJFMGV6NnF1SUpXQWNlY1pYY2xadGpEcGxjSFRyUU1CakpMUldjcHJZNUhyOX…

ZOTA — Frequently Asked Questions

What is the current share price of Zota Health Care Limited (ZOTA)?

As of 2026-07-15 09:52 IST, Zota Health Care Limited (ZOTA) trades at ₹1,398.50 on NSE. Its 52-week range is ₹1,043.10 to ₹1,687.00.

What is the market capitalisation of ZOTA?

Zota Health Care Limited (ZOTA) has a market capitalisation of ₹4,004.61 Cr on NSE.

What is the P/E ratio of ZOTA?

ZOTA trades at a trailing price-to-earnings (P/E) ratio of -67.63. The industry average P/E is 39.97. Its price-to-book (P/B) ratio is 13.95.

Does ZOTA pay a dividend?

Zota Health Care Limited (ZOTA) currently offers a dividend yield of 0.07%.

What is the return on equity (ROE) of ZOTA?

ZOTA has a return on equity (ROE) of -10.66%. Its return on capital employed (ROCE) is -6.99%.

Is ZOTA a good stock to buy?

This page provides a data-driven analysis of Zota Health Care Limited (ZOTA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space